Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
49,594,356
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
7,611,956
-
Shares change
-
+821,186
-
Total reported value, excl. options
-
$46,811,342
-
Value change
-
+$1,064,384
-
Put/Call ratio
-
19%
-
Number of buys
-
40
-
Number of sells
-
-23
-
Price
-
$6.15
Significant Holders of PDS Biotechnology Corp - Common (PDSB) as of Q1 2023
80 filings reported holding PDSB - PDS Biotechnology Corp - Common as of Q1 2023.
PDS Biotechnology Corp - Common (PDSB) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,611,956 shares
of 49,594,356 outstanding shares and own 15% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1,298,475 shares), MILLENNIUM MANAGEMENT LLC (596,272 shares), TWO SIGMA INVESTMENTS, LP (589,050 shares), TWO SIGMA ADVISERS, LP (584,400 shares), BlackRock Inc. (460,117 shares), RENAISSANCE TECHNOLOGIES LLC (365,737 shares), LPL Financial LLC (328,247 shares), INSPIRION WEALTH ADVISORS, LLC (314,684 shares), GEODE CAPITAL MANAGEMENT, LLC (292,253 shares), and FIRST MANHATTAN CO. LLC. (271,576 shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.